The Pharma Data

AUGUST 20, 2020

The drugmakers lost out to domestic producers, which in some cases undercut prices for established medicines by more than 90%, according to Jiemian. Among the drugs to lose contracts were Eli Lilly schizophrenia medicine Zyprexa and Pfizer’s Viagra, the publication said. Virtual Event. DEVELOP A UNIFIED SCIENTIFIC VOICE.

Research Analyst 52

Research Analyst Medicine Pharma Companies Marketing 52

Roots Analysis

JANUARY 23, 2024

Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases. The growing popularity of peptide-based drugs can be attributed to its high specificity, minimal drug-drug interactions, affinity, proven pharmacological value and favorable safety profiles.

Development 40

Development Contract Manufacturing Drugs Manufacturing 40

The Pharma Data

DECEMBER 31, 2020

Reimer replaces Charlotte Russel and will be responsible for Alligator’s drug development candidates, with an emphasis on bringing mitazalimab and ATOR-1017 into Phase II efficacy studies. Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector.

Gene Therapy 52

Gene Therapy Engineer Gene Research Analyst 52

The Pharma Data

DECEMBER 28, 2020

28, 2020 /PRNewswire/ — Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist contract research organization (CRO) in Asia , today announced the appointment of Zidong Zhang as Chief Financial Officer (CFO) effective 4 January 2021. SHANGHAI and SYDNEY , Dec. ” ABOUT NOVOTECH HEALTH HOLDINGS.

Clinical Trials 40

Clinical Trials Clinical Trials Research Analyst Trials 40

Roots Analysis

FEBRUARY 23, 2024

These experts are like the superhero squad for medical research. This helps to speed up the process of making new medicines and finding cures for diseases. Companies are now turning to contract research organizations to help accelerate their workflow.

Antibody 40

Antibody Research Marketing Scientist 40

Pharmaceutical Technology

JANUARY 27, 2023

On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. Cablivi stops platelets from clumping together, which prevents small clots, and can be used along with other drugs that suppress the immune system.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

XTalks

JUNE 9, 2022

Still riding high on the approval of its dual-targeting GIP/GLP-1 injection Mounjaro (tirzepatide) for the treatment of type 2 diabetes, Eli Lilly continues to forage the path ahead with the drug, sharing new analyses that continues to build a strong case for it as a weight loss injection for obese patients. cm reduction, 10 mg a 19.4

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research Analyst 52